Titulo:
.
Guardado en:
0121-5426
2538-9513
25
2016-12-08
Revista Colombiana de Neumología - 2017
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
| id |
metarevistapublica_asoneumocito_revistacolombianadeneumologia_28_article_132 |
|---|---|
| record_format |
ojs |
| spelling |
Tumor necrosis factor-alpha (TNF-α) inhibitors offer a strategic therapeutic target in stark contrast with traditional immunosuppressant agents used in the treatment of multiple inflammatory diseases. These biological agents have a high impact on the reduction of signs and symptoms, as well as on the functional recovery of a great variety of diseases of autoimmune etiology. It has been determined, on the basis of data from epidemiological and clinical studies, that there is an increased susceptibility to infections secondary to inhibition of the production of different cytokines; a great variety of infections, especially of the granulomatous and fungal types, have been reported with the use of TNF-α. We report a case of P. jiroveci pneumonia in a female patient who received treatment with adalimumab. Vela Lozada, MD., Fernando Londoño Trujillo, MD, MSc., Darío Rojas, MD., Juan Carlos Pneumocystis jirovecii adalimumab pneumonia immune compromise Pneumocystis jirovecii adalimumab neumonía inmunocompromiso 25 1 Artículo de revista Journal article 2016-12-08T22:42:03Z 2016-12-08T22:42:03Z 2016-12-08 application/pdf Asociación Colombiana de Neumología y Cirugía de Tórax Revista Colombiana de Neumología 0121-5426 2538-9513 https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/132 10.30789/rcneumologia.v25.n1.2013.132 https://doi.org/10.30789/rcneumologia.v25.n1.2013.132 spa https://creativecommons.org/licenses/by-nc-sa/4.0/ Revista Colombiana de Neumología - 2017 https://revistas.asoneumocito.org/index.php/rcneumologia/article/download/132/125 info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_dcae04bc http://purl.org/redcol/resource_type/ARTREV info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Publication |
| institution |
ASOCIACION COLOMBIANA DE NEUMOLOGIA Y CIRUGIA DE TORAX |
| thumbnail |
https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADENEUMOLOGIAYCIRUGIADETORAX/logo.png |
| country_str |
Colombia |
| collection |
Revista Colombiana de Neumología |
| description_eng |
Tumor necrosis factor-alpha (TNF-α) inhibitors offer a strategic therapeutic target in stark contrast with traditional immunosuppressant agents used in the treatment of multiple inflammatory diseases. These biological agents have a high impact on the reduction of signs and symptoms, as well as on the functional recovery of a great variety of diseases of autoimmune etiology. It has been determined, on the basis of data from epidemiological and clinical studies, that there is an increased susceptibility to infections secondary to inhibition of the production of different cytokines; a great variety of infections, especially of the granulomatous and fungal types, have been reported with the use of TNF-α. We report a case of P. jiroveci pneumonia in a female patient who received treatment with adalimumab.
|
| author |
Vela Lozada, MD., Fernando Londoño Trujillo, MD, MSc., Darío Rojas, MD., Juan Carlos |
| spellingShingle |
Vela Lozada, MD., Fernando Londoño Trujillo, MD, MSc., Darío Rojas, MD., Juan Carlos Pneumocystis jirovecii adalimumab pneumonia immune compromise Pneumocystis jirovecii adalimumab neumonía inmunocompromiso |
| author_facet |
Vela Lozada, MD., Fernando Londoño Trujillo, MD, MSc., Darío Rojas, MD., Juan Carlos |
| topic |
Pneumocystis jirovecii adalimumab pneumonia immune compromise Pneumocystis jirovecii adalimumab neumonía inmunocompromiso |
| topic_facet |
Pneumocystis jirovecii adalimumab pneumonia immune compromise Pneumocystis jirovecii adalimumab neumonía inmunocompromiso |
| topicspa_str_mv |
Pneumocystis jirovecii adalimumab neumonía inmunocompromiso |
| citationvolume |
25 |
| citationissue |
1 |
| publisher |
Asociación Colombiana de Neumología y Cirugía de Tórax |
| ispartofjournal |
Revista Colombiana de Neumología |
| source |
https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/132 |
| language |
spa |
| format |
Article |
| rights |
https://creativecommons.org/licenses/by-nc-sa/4.0/ Revista Colombiana de Neumología - 2017 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 |
| type_driver |
info:eu-repo/semantics/article |
| type_coar |
http://purl.org/coar/resource_type/c_6501 |
| type_version |
info:eu-repo/semantics/publishedVersion |
| type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| type_content |
Text |
| publishDate |
2016-12-08 |
| date_accessioned |
2016-12-08T22:42:03Z |
| date_available |
2016-12-08T22:42:03Z |
| url |
https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/132 |
| url_doi |
https://doi.org/10.30789/rcneumologia.v25.n1.2013.132 |
| issn |
0121-5426 |
| eissn |
2538-9513 |
| doi |
10.30789/rcneumologia.v25.n1.2013.132 |
| url2_str_mv |
https://revistas.asoneumocito.org/index.php/rcneumologia/article/download/132/125 |
| _version_ |
1811200696756731904 |